Orchid Pharma Q2 EBIDTA rises 104%, revenue up 36% on increasing sales
NEW DELHI: Orchid Pharma today announced their Q2'22 results. Fuelled by increasing sales and a laser sharp focus on costs,...
Day: November 16, 2022
Aurobindo Pharma receives EIR from USFDA for its Andhra Pradesh facility
NEW DELHI: Aurobindo Pharma Ltd on Wednesday said it has received an Establishment Inspection Report (EIR) from the US health...
